2. Gene
  3. Scd1 - stearoyl-Coenzyme A desaturase 1 Gene

Scd1 - stearoyl-Coenzyme A desaturase 1 Gene

  • Gene
  • Protein
  • Agent
Mus musculus

Also known as ab; Scd; Scd-1

Gene ID: 20249 | Gene type: protein coding

About Scd1

Chromosome 19: 44,382,894-44,396,318 reverse strand.GRCm39:CM001012.3

This gene has 3 transcripts (splice variants), 29 orthologues, 3 paralogues and is associated with 79 phenotypes. Biased expression in subcutaneous fat pad adult (RPKM 3754.4), mammary gland adult (RPKM 322.4) and 5 other tissues.

Summary

Enables metal ion binding activity; palmitoyl-CoA 9-desaturase activity; and stearoyl-CoA 9-desaturase activity. Involved in several processes, including Cholesterol esterification; positive regulation of cold-induced thermogenesis; and tarsal gland development. Acts upstream of or within several processes, including brown fat cell differentiation; monounsaturated fatty acid biosynthetic process; and white fat cell differentiation. Is integral component of endoplasmic reticulum membrane. Is expressed in several structures, including adipose tissue; central nervous system; cranium; integumental system; and liver. Human ortholog(s) of this gene implicated in autosomal dominant nonsyndromic deafness 79. Orthologous to several human genes including SCD (stearoyl-CoA desaturase). [provided by Alliance of Genome Resources, Apr 2022]

Scd1 Products(1)

mRNA Protein Name
NM_009127.4 NP_033153.2 acyl-CoA desaturase 1

Scd1 Protein Structure

Delta9-FADS-like

Delta9-FADS-like: cd03505 (92 - 332)

  • 0
  • 100
  • 200
  • 300
  • 355 a.a.
Protein Preferred Names Protein Names

acyl-CoA desaturase 1

asebia

delta(9)-desaturase 1

fatty acid desaturase 1

stearoyl-CoA desaturase 1

Related Agents

Clinical Phase
Bioactive Molecules (3)
Cat. No. Product Name Effect
Purity Phase
HY-19796 Icomidocholic acid ≥99.0% Phase 3
HY-13070 MK-8245 Inhibitor 99.04% Phase 2
HY-13077 MK-8245 Trifluoroacetate Inhibitor 98.09% Phase 2
Pre-clinical Phase
Bioactive Molecules (26)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-50709 A939572 Inhibitor 99.98% Unkown
HY-15823 CAY10566 Inhibitor 99.82% Unkown
HY-15822 MF-438 Inhibitor 99.92% Unkown
HY-12756A E6446 dihydrochloride 99.96% Unkown
HY-124751 YTX-465 Inhibitor 99.06% Unkown
HY-148788 Osivelotor 99.83% Unkown
HY-N6807 Elemicin Inhibitor 99.22% Unkown
HY-100249 XEN723 Inhibitor 99.90% Unkown
HY-127143 Sterculic acid Inhibitor ≥99.0% Unkown
HY-141525 SCD1 inhibitor-4 Inhibitor 98.93% Unkown
HY-155033 SSI-4 Inhibitor 99.95% Unkown
HY-12756 E6446 ≥98.0% Unkown
HY-112812 SCD1 inhibitor-1 Inhibitor 99.78% Unkown
HY-139077 SCD1 inhibitor-3 Inhibitor 98.55% Unkown
HY-155403 SCD1/5-IN-1 Inhibitor 99.58% Unkown
HY-159098 dWIZ-1 / Unkown
HY-111315 XEN103 Inhibitor / Unkown
HY-118117 Rovatirelin / Unkown
HY-150125 SCD1-IN-1 Inhibitor / Unkown
HY-152775A RK-0133114 Inhibitor / Unkown
HY-161787 G9a-IN-2 Inhibitor / Unkown
HY-E70265 18:0 Coenzyme A triammonium / Unkown
HY-N8144 Niga-ichigoside F1 ≥99.0% Unkown
HY-RS12496 Scd1 Mouse Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-155209 SCD1 inhibitor-5 Inhibitor / Unkown
HY-W013627S trans,trans-2,4-Decadienal-d4 / Unkown